Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Delini-Stula

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Psychopharmacology|January 1, 1983
Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxinD J Dooley, E Mogilnicka, A Delini-Stula, et al.
International Journal of Psychiatry in Clinical Practice|June 13, 2014
Assessment of sexual dysfunction in depressed patients and reporting attitudes in routine daily practice: Results of the postmarketing observational studies with moclobemide, a reversible MAO-A inhibitorM Philipp, A Delini-Stula, D Baier, et al.
Pharmacopsychiatry|May 20, 1999
Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor--results of the drug utilization observation studiesA Delini-Stula, D Baier, R Kohnen, et al.
Advances in Biochemical Psychopharmacology|January 1, 1982
Stereospecificity of behavioural and biochemical responses to oxaprotiline--a new antidepressantA Delini-Stula, K Hauser, P Baumann, et al.
International Clinical Psychopharmacology|July 1, 1987
First clinical experience with ifoxetine, a new 5-HT reuptake blocker with particular emphasis on the side-effect profile of the 5-HT-uptake inhibiting drugsA Delini-Stula, R Fischbach, J M Gauthier, et al.
Revue Medicale Suisse|March 16, 2007
[Psychiatry]J M Aubry, A Delini-Stula, N Gervasoni, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1983
Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidaseP C Waldmeier, P A Baumann, A Delini-Stula, et al.
Arzneimittel-Forschung|January 1, 1984
Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112)F Märki, O Büch, A Delini-Stula, et al.
Arzneimittel-Forschung|December 1, 1986
Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptakeR Ortmann, E Radeke, O Buech, et al.
Pharmacopsychiatry|November 1, 1988
Non-response to antidepressants: risk factors and therapeutic possibilitiesH J Möller, W Kissling, P Baumann, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Psychopharmacology|January 1, 1983
Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxinD J Dooley, E Mogilnicka, A Delini-Stula, et al.
International Journal of Psychiatry in Clinical Practice|June 13, 2014
Assessment of sexual dysfunction in depressed patients and reporting attitudes in routine daily practice: Results of the postmarketing observational studies with moclobemide, a reversible MAO-A inhibitorM Philipp, A Delini-Stula, D Baier, et al.
Pharmacopsychiatry|May 20, 1999
Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor--results of the drug utilization observation studiesA Delini-Stula, D Baier, R Kohnen, et al.
Advances in Biochemical Psychopharmacology|January 1, 1982
Stereospecificity of behavioural and biochemical responses to oxaprotiline--a new antidepressantA Delini-Stula, K Hauser, P Baumann, et al.
International Clinical Psychopharmacology|July 1, 1987
First clinical experience with ifoxetine, a new 5-HT reuptake blocker with particular emphasis on the side-effect profile of the 5-HT-uptake inhibiting drugsA Delini-Stula, R Fischbach, J M Gauthier, et al.
Revue Medicale Suisse|March 16, 2007
[Psychiatry]J M Aubry, A Delini-Stula, N Gervasoni, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1983
Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidaseP C Waldmeier, P A Baumann, A Delini-Stula, et al.
Arzneimittel-Forschung|January 1, 1984
Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112)F Märki, O Büch, A Delini-Stula, et al.
Arzneimittel-Forschung|December 1, 1986
Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptakeR Ortmann, E Radeke, O Buech, et al.
Pharmacopsychiatry|November 1, 1988
Non-response to antidepressants: risk factors and therapeutic possibilitiesH J Möller, W Kissling, P Baumann, et al.
Pageof 8